Cargando…
Off label therapies for testosterone replacement
The incidence of hypogonadism has been steadily increasing over the last few years. Exogenous testosterone has been the standard treatment for hypogonadal men, but is associated with suppression of spermatogenesis as well as other possible adverse effects. There are other medications, currently cons...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182219/ https://www.ncbi.nlm.nih.gov/pubmed/28078215 http://dx.doi.org/10.21037/tau.2016.08.15 |
_version_ | 1782485826307883008 |
---|---|
author | DiGiorgio, Lorenzo Sadeghi-Nejad, Hossein |
author_facet | DiGiorgio, Lorenzo Sadeghi-Nejad, Hossein |
author_sort | DiGiorgio, Lorenzo |
collection | PubMed |
description | The incidence of hypogonadism has been steadily increasing over the last few years. Exogenous testosterone has been the standard treatment for hypogonadal men, but is associated with suppression of spermatogenesis as well as other possible adverse effects. There are other medications, currently considered “off label” for androgen replenishment, that exert their effect through modulation of the hypothalamic-gonadal axis. These medications increase endogenous testosterone levels and offer a different therapeutic approach. This review will focus on these alternative (off-label) therapies for androgen replacement in men. |
format | Online Article Text |
id | pubmed-5182219 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-51822192017-01-11 Off label therapies for testosterone replacement DiGiorgio, Lorenzo Sadeghi-Nejad, Hossein Transl Androl Urol Review Article The incidence of hypogonadism has been steadily increasing over the last few years. Exogenous testosterone has been the standard treatment for hypogonadal men, but is associated with suppression of spermatogenesis as well as other possible adverse effects. There are other medications, currently considered “off label” for androgen replenishment, that exert their effect through modulation of the hypothalamic-gonadal axis. These medications increase endogenous testosterone levels and offer a different therapeutic approach. This review will focus on these alternative (off-label) therapies for androgen replacement in men. AME Publishing Company 2016-12 /pmc/articles/PMC5182219/ /pubmed/28078215 http://dx.doi.org/10.21037/tau.2016.08.15 Text en 2016 Translational Andrology and Urology. All rights reserved. |
spellingShingle | Review Article DiGiorgio, Lorenzo Sadeghi-Nejad, Hossein Off label therapies for testosterone replacement |
title | Off label therapies for testosterone replacement |
title_full | Off label therapies for testosterone replacement |
title_fullStr | Off label therapies for testosterone replacement |
title_full_unstemmed | Off label therapies for testosterone replacement |
title_short | Off label therapies for testosterone replacement |
title_sort | off label therapies for testosterone replacement |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5182219/ https://www.ncbi.nlm.nih.gov/pubmed/28078215 http://dx.doi.org/10.21037/tau.2016.08.15 |
work_keys_str_mv | AT digiorgiolorenzo offlabeltherapiesfortestosteronereplacement AT sadeghinejadhossein offlabeltherapiesfortestosteronereplacement |